Clinical Trial Update: Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of irinotecan liposome injection in patients with advanced biliary tract cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Extrahepatic Cholangiocarcinoma
• Gallbladder Carcinoma
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Irinotecan liposome injection (irinotecan liposome injection)

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma | Phase 2 | Status: TERMINATED